149 related articles for article (PubMed ID: 28571120)
1. Development of Physiologically Based Organ Models to Evaluate the Pharmacokinetics of Drugs in the Testes and the Thyroid Gland.
Pilari S; Gaub T; Block M; Görlitz L
CPT Pharmacometrics Syst Pharmacol; 2017 Aug; 6(8):532-542. PubMed ID: 28571120
[TBL] [Abstract][Full Text] [Related]
2. Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals.
Schlender JF; Meyer M; Thelen K; Krauss M; Willmann S; Eissing T; Jaehde U
Clin Pharmacokinet; 2016 Dec; 55(12):1573-1589. PubMed ID: 27351180
[TBL] [Abstract][Full Text] [Related]
3. Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition.
Poulin P; Theil FP
J Pharm Sci; 2002 May; 91(5):1358-70. PubMed ID: 11977112
[TBL] [Abstract][Full Text] [Related]
4. Development of a Generic Fetal Physiologically Based Pharmacokinetic Model and Prediction of Human Maternal and Fetal Organ Concentrations of Cefuroxime.
Liu XI; Green DJ; van den Anker J; Ahmadzia HK; Burckart GJ; Dallmann A
Clin Pharmacokinet; 2024 Jan; 63(1):69-78. PubMed ID: 37962827
[TBL] [Abstract][Full Text] [Related]
5. Novel physiologically based pharmacokinetic modeling of patupilone for human pharmacokinetic predictions.
Xia B; Heimbach T; Lin TH; He H; Wang Y; Tan E
Cancer Chemother Pharmacol; 2012 Jun; 69(6):1567-82. PubMed ID: 22526410
[TBL] [Abstract][Full Text] [Related]
6. Integration of dissolution into physiologically-based pharmacokinetic models III: PK-Sim®.
Willmann S; Thelen K; Lippert J
J Pharm Pharmacol; 2012 Jul; 64(7):997-1007. PubMed ID: 22686345
[TBL] [Abstract][Full Text] [Related]
7. Investigation of an alternative generic model for predicting pharmacokinetic changes during physiological stress.
Peng HT; Edginton AN; Cheung B
J Clin Pharmacol; 2013 Oct; 53(10):1048-57. PubMed ID: 23852614
[TBL] [Abstract][Full Text] [Related]
8. Physiologically based pharmacokinetic (PBPK) modelling tools: how to fit with our needs?
Bouzom F; Ball K; Perdaems N; Walther B
Biopharm Drug Dispos; 2012 Mar; 33(2):55-71. PubMed ID: 22228149
[TBL] [Abstract][Full Text] [Related]
9. Physiologically based pharmacokinetic modelling of Busulfan: a new approach to describe and predict the pharmacokinetics in adults.
Diestelhorst C; Boos J; McCune JS; Russell J; Kangarloo SB; Hempel G
Cancer Chemother Pharmacol; 2013 Nov; 72(5):991-1000. PubMed ID: 24061863
[TBL] [Abstract][Full Text] [Related]
10. PBPK models in risk assessment--A focus on chloroprene.
DeWoskin RS
Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
[TBL] [Abstract][Full Text] [Related]
11. Development of a Physiologically-Based Pharmacokinetic Model for Preterm Neonates: Evaluation with In Vivo Data.
Claassen K; Thelen K; Coboeken K; Gaub T; Lippert J; Allegaert K; Willmann S
Curr Pharm Des; 2015; 21(39):5688-98. PubMed ID: 26323410
[TBL] [Abstract][Full Text] [Related]
12. An introduction to physiologically-based pharmacokinetic models.
Upton RN; Foster DJ; Abuhelwa AY
Paediatr Anaesth; 2016 Nov; 26(11):1036-1046. PubMed ID: 27550716
[TBL] [Abstract][Full Text] [Related]
13. Whole-Body Physiologically Based Pharmacokinetic Modeling of Trastuzumab and Prediction of Human Pharmacokinetics.
Bae DJ; Kim SY; Bae SM; Hwang AK; Pak KC; Yoon S; Lim HS
J Pharm Sci; 2019 Jun; 108(6):2180-2190. PubMed ID: 30716331
[TBL] [Abstract][Full Text] [Related]
14. Physiologically-Based Pharmacokinetic Modeling vs. Allometric Scaling for the Prediction of Infliximab Pharmacokinetics in Pediatric Patients.
Malik PRV; Edginton AN
CPT Pharmacometrics Syst Pharmacol; 2019 Nov; 8(11):835-844. PubMed ID: 31343836
[TBL] [Abstract][Full Text] [Related]
15. Use of in vitro data in developing a physiologically based pharmacokinetic model: Carbaryl as a case study.
Yoon M; Kedderis GL; Yan GZ; Clewell HJ
Toxicology; 2015 Jun; 332():52-66. PubMed ID: 24863738
[TBL] [Abstract][Full Text] [Related]
16. Physiologically based pharmacokinetics (PBPK).
Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
[TBL] [Abstract][Full Text] [Related]
17. Windows based general PBPK/PD modeling software.
Luecke RH; Pearce BA; Wosilait WD; Doerge DR; Slikker W; Young JF
Comput Biol Med; 2008 Sep; 38(9):962-78. PubMed ID: 18657803
[TBL] [Abstract][Full Text] [Related]
18. Generic Workflow to Predict Medicine Concentrations in Human Milk Using Physiologically-Based Pharmacokinetic (PBPK) Modelling-A Contribution from the ConcePTION Project.
Nauwelaerts N; Macente J; Deferm N; Bonan RH; Huang MC; Van Neste M; Bibi D; Badee J; Martins FS; Smits A; Allegaert K; Bouillon T; Annaert P
Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242712
[TBL] [Abstract][Full Text] [Related]
19. Development of a hybrid physiologically based pharmacokinetic model with drug-specific scaling factors in rat to improve prediction of human pharmacokinetics.
Sayama H; Komura H; Kogayu M; Iwaki M
J Pharm Sci; 2013 Nov; 102(11):4193-204. PubMed ID: 24018828
[TBL] [Abstract][Full Text] [Related]
20. The successes and failures of physiologically based pharmacokinetic modeling: there is room for improvement.
Poggesi I; Snoeys J; Van Peer A
Expert Opin Drug Metab Toxicol; 2014 May; 10(5):631-5. PubMed ID: 24517185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
